Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications

Lillo, Antonietta M.; Velappan, Nileena; Kelliher, Julia M.; Watts, Austin J.; Merriman, Samuel P.; Vuyisich, Grace; Lilley, Laura M.; Coombs, Kent E.; Mastren, Tara; Teshima, Munehiro; Stein, Benjamin W.; Wagner, Gregory L.; Iyer, Srinivas; Bradbury, Andrew R. M.; Harris, Jennifer Foster; Dichosa, Armand E.; Kozimor, Stosh A.

doi:10.2147/itt.s267077

Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications

Journal Article · Fri Nov 27 00:00:00 EST 2020 · ImmunoTargets and Therapy

DOI:https://doi.org/10.2147/itt.s267077· OSTI ID:1755889

^[1]; ^[1]; ^[1]; ^[1]; Merriman, Samuel P. ^[1]; ^[1]; ^[1]; ^[1]; ^[1]; ^[1]; ^[1]; Wagner, Gregory L. ^[1]; Iyer, Srinivas ^[1]; ^[2]; ^[1]; ^[1]; ^[1]

Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Specifica Inc., Santa Fe, NM (United States)

Yersinia pestis is a category A infective agent that causes bubonic, septicemic, and pneumonic plague. Notably, the acquisition of antimicrobial or multidrug resistance through natural or purposed means qualifies Y. pestis as a potential biothreat agent. Therefore, high-quality antibodies designed for accurate and sensitive Y. pestis diagnostics, and therapeutics potentiating or replacing traditional antibiotics are of utmost need for national security and public health preparedness. Here, we describe a set of human monoclonal immunoglobulins (IgG1s) targeting Y. pestis fraction 1 (F1) antigen, previously derived from in vitro evolution of a phage-display library of single-chain antibodies (scFv). We extensively characterized these antibodies and their effect on bacterial and mammalian cells via: ELISA, flow cytometry, mass spectrometry, spectroscopy, and various metabolic assays. Two of our anti-F1 IgG (αF1Ig 2 and αF1Ig 8) stood out for high production yield, specificity, and stability. These two antibodies were additionally attractive in that they displayed picomolar affinity, did not compete when binding Y. pestis, and retained immunoreactivity upon chemical derivatization. Most importantly, these antibodies detected < 1,000 Y. pestis cells in sandwich ELISA, did not harm respiratory epithelial cells, induced Y. pestis agglutination at low concentration (350 nM), and caused apparent reduction in cell growth when radiolabeled at a nonagglutinating concentration (34 nM). These antibodies are amenable to the development of accurate and sensitive diagnostics and immuno/radioimmunotherapeutics.

View Accepted Manuscript (DOE)

Research Organization:: Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)

Sponsoring Organization:: USDOE Laboratory Directed Research and Development (LDRD) Program; USDOE Office of Science (SC), Nuclear Physics (NP)

Grant/Contract Number:: 89233218CNA000001

OSTI ID:: 1755889

Report Number(s):: LA-UR--20-30360

Journal Information:: ImmunoTargets and Therapy, Journal Name: ImmunoTargets and Therapy Vol. 9; ISSN 2253-1556

Publisher:: Dove PressCopyright Statement

Country of Publication:: United States

Language:: English

References (66)

Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. di Marzo Veronese, F.; Reitz, M. S.; Gupta, G. Journal of Biological Chemistry, Vol. 268, Issue 34 https://doi.org/10.1016/S0021-9258(19)74471-8	journal	December 1993
A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain. Posnett, D. N.; McGrath, H.; Tam, J. P. Journal of Biological Chemistry, Vol. 263, Issue 4 https://doi.org/10.1016/S0021-9258(19)77935-6	journal	February 1988
Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay Benedict, Chris A.; MacKrell, Albert J.; Anderson, W. French Journal of Immunological Methods, Vol. 201, Issue 2 https://doi.org/10.1016/S0022-1759(96)00227-X	journal	February 1997
Development and testing of a rapid diagnostic test for bubonic and pneumonic plague Chanteau, Suzanne; Rahalison, Lila; Ralafiarisoa, Lalao The Lancet, Vol. 361, Issue 9353 https://doi.org/10.1016/S0140-6736(03)12270-2	journal	January 2003
Immunomodulators in infectious diseases: panoply of possibilites Masihi, K. Noel International Journal of Immunopharmacology, Vol. 22, Issue 12 https://doi.org/10.1016/S0192-0561(00)00074-6	journal	December 2000
An²²⁵Ac/²¹³Bi generator system for therapeutic clinical applications: construction and operation McDevitt, Michael R.; Finn, Ronald D.; Sgouros, George Applied Radiation and Isotopes, Vol. 50, Issue 5, p. 895-904 https://doi.org/10.1016/S0969-8043(98)00151-1	journal	May 1999
Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick Chanteau, Suzanne; Rahalison, Lila; Ratsitorahina, Mahery International Journal of Medical Microbiology, Vol. 290, Issue 3, p. 279-283 https://doi.org/10.1016/S1438-4221(00)80126-5	journal	July 2000
Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein Wang, R.; Song, A.; Levin, J. Antiviral Research, Vol. 80, Issue 2 https://doi.org/10.1016/j.antiviral.2008.06.002	journal	November 2008
Minimization of Bacterial Size Allows for Complement Evasion and Is Overcome by the Agglutinating Effect of Antibody Dalia, Ankur B.; Weiser, Jeffrey N. Cell Host & Microbe, Vol. 10, Issue 5 https://doi.org/10.1016/j.chom.2011.09.009	journal	November 2011
Antibodies for the treatment of bacterial infections: current experience and future prospects Bebbington, Christopher; Yarranton, Geoffrey Current Opinion in Biotechnology, Vol. 19, Issue 6 https://doi.org/10.1016/j.copbio.2008.10.002	journal	December 2008
Where are we with monoclonal antibodies for multidrug-resistant infections? McConnell, Michael J. Drug Discovery Today, Vol. 24, Issue 5 https://doi.org/10.1016/j.drudis.2019.03.002	journal	May 2019
Evaluation of a standardized F1 capsular antigen capture ELISA test kit for the rapid diagnosis of plague Splettstoesser, Wolf D.; Rahalison, Lila; Grunow, Roland FEMS Immunology & Medical Microbiology, Vol. 41, Issue 2 https://doi.org/10.1016/j.femsim.2004.02.005	journal	June 2004
Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains Abhinandan, K. R.; Martin, Andrew C. R. Molecular Immunology, Vol. 45, Issue 14 https://doi.org/10.1016/j.molimm.2008.05.022	journal	August 2008
Antibody–Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections Mariathasan, Sanjeev; Tan, Man-Wah Trends in Molecular Medicine, Vol. 23, Issue 2 https://doi.org/10.1016/j.molmed.2016.12.008	journal	February 2017
Combination approaches to combat multidrug-resistant bacteria Worthington, Roberta J.; Melander, Christian Trends in Biotechnology, Vol. 31, Issue 3 https://doi.org/10.1016/j.tibtech.2012.12.006	journal	March 2013
The Increasingly Human and Profitable Monoclonal Antibody Market Grilo, António L.; Mantalaris, A. Trends in Biotechnology, Vol. 37, Issue 1 https://doi.org/10.1016/j.tibtech.2018.05.014	journal	January 2019
Production of Ac-225 from Th-229 for Targeted α Therapy Apostolidis, C.; Molinet, R.; Rasmussen, G. Analytical Chemistry, Vol. 77, Issue 19 https://doi.org/10.1021/ac0580114	journal	October 2005
Targeting Heat Shock Proteins on Cancer Cells: Selection, Characterization, and Cell-Penetrating Properties of a Peptidic GRP78 Ligand ^† Kim, Youngsoo; Lillo, Antonietta M.; Steiniger, Sebastian C. J. Biochemistry, Vol. 45, Issue 31 https://doi.org/10.1021/bi060264j	journal	August 2006
Optimal Screening of Surface-Displayed Polypeptide Libraries Boder, E. T.; Wittrup, K. D. Biotechnology Progress, Vol. 14, Issue 1 https://doi.org/10.1021/bp970144q	journal	February 1998
Phage Display Smith, George P.; Petrenko, Valery A. Chemical Reviews, Vol. 97, Issue 2 https://doi.org/10.1021/cr960065d	journal	April 1997
Exploiting recombination in single bacteria to make large phage antibody libraries Sblattero, Daniele; Bradbury, Andrew Nature Biotechnology, Vol. 18, Issue 1 https://doi.org/10.1038/71958	journal	January 2000
Antibody blocks acquisition of bacterial colonization through agglutination Roche, A. M.; Richard, A. L.; Rahkola, J. T. Mucosal Immunology, Vol. 8, Issue 1 https://doi.org/10.1038/mi.2014.55	journal	June 2014
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index Junutula, Jagath R.; Raab, Helga; Clark, Suzanna Nature Biotechnology, Vol. 26, Issue 8 https://doi.org/10.1038/nbt.1480	journal	July 2008
Beyond natural antibodies: the power of in vitro display technologies Bradbury, Andrew R. M.; Sidhu, Sachdev; Dübel, Stefan Nature Biotechnology, Vol. 29, Issue 3 https://doi.org/10.1038/nbt.1791	journal	March 2011
Spectroscopic and computational investigation of actinium coordination chemistry Ferrier, Maryline G.; Batista, Enrique R.; Berg, John M. Nature Communications, Vol. 7, Issue 1 https://doi.org/10.1038/ncomms12312	journal	August 2016
Capturing and cultivating single bacterial cells in gel microdroplets to obtain near-complete genomes Dichosa, Armand E. K.; Daughton, Ashlynn R.; Reitenga, Krista G. Nature Protocols, Vol. 9, Issue 3 https://doi.org/10.1038/nprot.2014.034	journal	February 2014
Antibody therapy of cancer Scott, Andrew M.; Wolchok, Jedd D.; Old, Lloyd J. Nature Reviews Cancer, Vol. 12, Issue 4 https://doi.org/10.1038/nrc3236	journal	March 2012
Radiotherapy and immunotherapy: a beneficial liaison? Weichselbaum, Ralph R.; Liang, Hua; Deng, Liufu Nature Reviews Clinical Oncology, Vol. 14, Issue 6 https://doi.org/10.1038/nrclinonc.2016.211	journal	January 2017
Antibody targeted drugs as cancer therapeutics Schrama, David; Reisfeld, Ralph A.; Becker, Jürgen C. Nature Reviews Drug Discovery, Vol. 5, Issue 2 https://doi.org/10.1038/nrd1957	journal	January 2006
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids Axup, J. Y.; Bajjuri, K. M.; Ritland, M. Proceedings of the National Academy of Sciences, Vol. 109, Issue 40 https://doi.org/10.1073/pnas.1211023109	journal	September 2012
Biological Warfare and Bioterrorism: A Historical Review Riedel, Stefan Baylor University Medical Center Proceedings, Vol. 17, Issue 4 https://doi.org/10.1080/08998280.2004.11928002	journal	October 2004
Selection and characterization of FcεRI phospho-ITAM specific antibodies Velappan, Nileena; Mahajan, Avanika; Naranjo, Leslie mAbs, Vol. 11, Issue 7 https://doi.org/10.1080/19420862.2019.1632113	journal	July 2019
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America Spellberg, B.; Guidos, R.; Gilbert, D. Clinical Infectious Diseases, Vol. 46, Issue 2 https://doi.org/10.1086/524891	journal	January 2008
Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus Zhang, Shuliu; Vogt, Matthew R.; Oliphant, Theodore The Journal of Infectious Diseases, Vol. 200, Issue 2 https://doi.org/10.1086/599794	journal	July 2009
Avirulent Strains of Pasteurella Pestis Jawetz, E.; Meyer, K. F. Journal of Infectious Diseases, Vol. 73, Issue 2 https://doi.org/10.1093/infdis/73.2.124	journal	September 1943
Epitope mapping in cell surface proteins by site-directed masking: defining the structural elements of NTPDase3 inhibition by a monoclonal antibody Ivanenkov, V. V.; Crawford, P. A.; Toyama, A. Protein Engineering Design and Selection, Vol. 23, Issue 7 https://doi.org/10.1093/protein/gzq027	journal	May 2010
Intraspecific Diversity of Yersinia pestis Anisimov, A. P.; Lindler, L. E.; Pier, G. B. Clinical Microbiology Reviews, Vol. 17, Issue 2 https://doi.org/10.1128/CMR.17.2.434-464.2004	journal	April 2004
Yersinia pestis caf1 Variants and the Limits of Plague Vaccine Protection Quenee, L. E.; Cornelius, C. A.; Ciletti, N. A. Infection and Immunity, Vol. 76, Issue 5 https://doi.org/10.1128/IAI.00105-08	journal	March 2008
The Yersinia pestis caf1M1A1 Fimbrial Capsule Operon Promotes Transmission by Flea Bite in a Mouse Model of Bubonic Plague Sebbane, Florent; Jarrett, Clayton; Gardner, Donald Infection and Immunity, Vol. 77, Issue 3 https://doi.org/10.1128/IAI.00950-08	journal	December 2008
The Dependence of the Yersinia pestis Capsule on Pathogenesis Is Influenced by the Mouse Background Weening, Eric H.; Cathelyn, Jason S.; Kaufman, Greer Infection and Immunity, Vol. 79, Issue 2 https://doi.org/10.1128/IAI.00981-10	journal	November 2010
Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Hill, J.; Leary, S. E.; Griffin, K. F. Infection and immunity, Vol. 65, Issue 11 https://doi.org/10.1128/IAI.65.11.4476-4482.1997	journal	January 1997
Role of Fraction 1 Antigen of Yersinia pestis in Inhibition of Phagocytosis Du, Yidong; Rosqvist, Roland; Forsberg, Åke Infection and Immunity, Vol. 70, Issue 3 https://doi.org/10.1128/IAI.70.3.1453-1460.2002	journal	March 2002
Synergistic Protection of Mice against Plague with Monoclonal Antibodies Specific for the F1 and V Antigens of Yersinia pestis Hill, Jim; Copse, Catherine; Leary, Sophie Infection and Immunity, Vol. 71, Issue 4 https://doi.org/10.1128/IAI.71.4.2234-2238.2003	journal	April 2003
Administration of Antibody to the Lung Protects Mice against Pneumonic Plague Hill, Jim; Eyles, Jim E.; Elvin, Stephen J. Infection and Immunity, Vol. 74, Issue 5 https://doi.org/10.1128/IAI.74.5.3068-3070.2006	journal	May 2006
Characterization of an F1 Deletion Mutant of Yersinia pestis CO92, Pathogenic Role of F1 Antigen in Bubonic and Pneumonic Plague, and Evaluation of Sensitivity and Specificity of F1 Antigen Capture-Based Dipsticks Sha, J.; Endsley, J. J.; Kirtley, M. L. Journal of Clinical Microbiology, Vol. 49, Issue 5 https://doi.org/10.1128/JCM.00064-11	journal	March 2011
Comparison of Hand-Held Test Kits, Immunofluorescence Microscopy, Enzyme-Linked Immunosorbent Assay, and Flow Cytometric Analysis for Rapid Presumptive Identification of Yersinia pestis Tomaso, H.; Thullier, P.; Seibold, E. Journal of Clinical Microbiology, Vol. 45, Issue 10 https://doi.org/10.1128/JCM.00458-07	journal	July 2007
Staying in Shape: the Impact of Cell Shape on Bacterial Survival in Diverse Environments Yang, Desirée C.; Blair, Kris M.; Salama, Nina R. Microbiology and Molecular Biology Reviews, Vol. 80, Issue 1 https://doi.org/10.1128/MMBR.00031-15	journal	February 2016
Using phage display selected antibodies to dissect microbiomes for complete de novo genome sequencing of low abundance microbes Close, Devin W.; Ferrara, Fortunato; Dichosa, Armand EK BMC Microbiology, Vol. 13, Issue 1 https://doi.org/10.1186/1471-2180-13-270	journal	January 2013
Multiple Antimicrobial Resistance in Plague: An Emerging Public Health Risk Welch, Timothy J.; Fricke, W. Florian; McDermott, Patrick F. PLoS ONE, Vol. 2, Issue 3 https://doi.org/10.1371/journal.pone.0000309	journal	March 2007
Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model Xiao, Xiaodong; Zhu, Zhongyu; Dankmeyer, Jennifer L. PLoS ONE, Vol. 5, Issue 10 https://doi.org/10.1371/journal.pone.0013047	journal	October 2010
Development of Phage-Based Single Chain Fv Antibody Reagents for Detection of Yersinia pestis Lillo, Antonietta M.; Ayriss, Joanne E.; Shou, Yulin PLoS ONE, Vol. 6, Issue 12 https://doi.org/10.1371/journal.pone.0027756	journal	December 2011
Using Phage and Yeast Display to Select Hundreds of Monoclonal Antibodies: Application to Antigen 85, a Tuberculosis Biomarker Ferrara, Fortunato; Naranjo, Leslie A.; Kumar, Sandeep PLoS ONE, Vol. 7, Issue 11 https://doi.org/10.1371/journal.pone.0049535	journal	November 2012
Beyond Helper Phage: Using "Helper Cells" to Select Peptide Affinity Ligands Phipps, M. Lisa; Lillo, Antoinetta M.; Shou, Yulin PLOS ONE, Vol. 11, Issue 9 https://doi.org/10.1371/journal.pone.0160940	journal	September 2016
Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis Liu, Weicen; Ren, Jun; Zhang, Jinlong PLOS ONE, Vol. 12, Issue 5 https://doi.org/10.1371/journal.pone.0177012	journal	May 2017
Immunodiagnostics and immunosensor design (IUPAC Technical Report) Gubala, Vladimir; Klein, Reinhild; Templeton, Douglas M. Pure and Applied Chemistry, Vol. 86, Issue 10 https://doi.org/10.1515/pac-2013-1027	journal	October 2014
Lessons Learned about Pneumonic Plague Diagnosis from 2 Outbreaks, Democratic Republic of the Congo Bertherat, Eric; Thullier, Philippe; Shako, Jean Christophe Emerging Infectious Diseases, Vol. 17, Issue 5 https://doi.org/10.3201/eid1705.100029	journal	May 2011
Yersinia pestis: mechanisms of entry into and resistance to the host cell Ke, Yuehua; Chen, Zeliang; Yang, Ruifu Frontiers in Cellular and Infection Microbiology, Vol. 3 https://doi.org/10.3389/fcimb.2013.00106	journal	January 2013
Antibody Conjugates: From Heterogeneous Populations to Defined Reagents Dennler, Patrick; Fischer, Eliane; Schibli, Roger Antibodies, Vol. 4, Issue 3 https://doi.org/10.3390/antib4030197	journal	August 2015
Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections Wang-Lin, Shun; Balthasar, Joseph Antibodies, Vol. 7, Issue 1 https://doi.org/10.3390/antib7010005	journal	January 2018
The Role of Reactive-Oxygen-Species in Microbial Persistence and Inflammation Spooner, Ralee; Yilmaz, Özlem International Journal of Molecular Sciences, Vol. 12, Issue 1 https://doi.org/10.3390/ijms12010334	journal	January 2011
Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs) Yao, Houzong; Jiang, Feng; Lu, Aiping International Journal of Molecular Sciences, Vol. 17, Issue 2 https://doi.org/10.3390/ijms17020194	journal	February 2016
Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence Worthington, Roberta J.; Blackledge, Meghan S.; Melander, Christian Future Medicinal Chemistry, Vol. 5, Issue 11 https://doi.org/10.4155/fmc.13.58	journal	July 2013
Understanding and circumventing resistance to anticancer monoclonal antibodies Reslan, Lina; Dalle, Stéphane; Dumontet, Charles mAbs, Vol. 1, Issue 3 https://doi.org/10.4161/mabs.1.3.8292	journal	May 2009
Site-specific antibody drug conjugates for cancer therapy Panowski, Siler; Bhakta, Sunil; Raab, Helga mAbs, Vol. 6, Issue 1 https://doi.org/10.4161/mabs.27022	journal	November 2013
In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation Li, Bing; Fouts, Ashley E.; Stengel, Katharina mAbs, Vol. 6, Issue 2 https://doi.org/10.4161/mabs.27875	journal	January 2014
Protection of Mice from Fatal Bubonic and Pneumonic Plague by Passive Immunization with Monoclonal Antibodies against the F1 Protein of Yersinia pestis Anderson, George W.; Welkos, Susan L.; Bolt, Christopher R. The American Journal of Tropical Medicine and Hygiene, Vol. 56, Issue 4 https://doi.org/10.4269/ajtmh.1997.56.471	journal	April 1997

Similar Records

Development of Phage-Based Single Chain Fv Antibody Reagents for Detection of Yersinia pestis

Journal Article · Wed Dec 07 19:00:00 EST 2011 · PLoS ONE · OSTI ID:1627484

Lateral flow assay for detection of Yesinia pestis

Technical Report · Tue Nov 17 23:00:00 EST 2020 · OSTI ID:1726123

Related Subjects

60 APPLIED LIFE SCIENCES
LFA
RIT
immunoantibiotic
immunodiagnostic
immunotherapy
lateral flow assay
radioimmunotherapy
radiolabeling

Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications

Citation Formats

References (66)

Similar Records

Related Subjects